{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T08:54:10Z","timestamp":1770022450631,"version":"3.49.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.jad.2022.08.011","type":"journal-article","created":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T22:27:37Z","timestamp":1660256857000},"page":"177-186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Description of antidepressant withdrawal symptoms in clinical practice guidelines on depression: A systematic review"],"prefix":"10.1016","volume":"316","author":[{"given":"Anders","family":"S\u00f8rensen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karsten Juhl","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Munkholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2022.08.011_bb0005","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1097\/chi.0b013e318145ae1c","article-title":"Practice parameter for the assessment and treatment of children and adolescents with depressive disorders","volume":"46","year":"2007","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jad.2022.08.011_bb0010","series-title":"Practice Guideline for the Treatment of Patients With Major Depressive Disorder","year":"2010"},{"key":"10.1016\/j.jad.2022.08.011_bb0015","series-title":"Clinical Practice Guideline for the Treatment of Depression Across Three Cohorts","year":"2019"},{"key":"10.1016\/j.jad.2022.08.011_bb0020","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/gps.940","article-title":"Guideline for the management of late-life depression in primary care","volume":"18","author":"Baldwin","year":"2003","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.jad.2022.08.011_bb0025","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/15622970701227829","article-title":"World Federation of Societies of biological psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders in primary care","volume":"8","author":"Bauer","year":"2007","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2022.08.011_bb0030","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3109\/15622975.2014.1001786","article-title":"World Federation of Societies of biological psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders. Part 2: maintenance treatment of major depressive disorder-update 2015","volume":"16","author":"Bauer","year":"2015","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2022.08.011_bb0035","first-page":"141","article-title":"Guidelines for adolescent depression in primary care (GLAD-PC): Part II. Treatment and ongoing management","author":"Cheung","year":"2018","journal-title":"Pediatrics"},{"key":"10.1016\/j.jad.2022.08.011_bb0040","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/0269881115581093","article-title":"Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British Association for Psychopharmacology guidelines","volume":"29","author":"Cleare","year":"2015","journal-title":"J. Psychopharmacol. (Oxford)"},{"key":"10.1016\/j.jad.2022.08.011_bb0045","series-title":"Depression. MOH Clinical Practice Guidelines","year":"2012"},{"key":"10.1016\/j.jad.2022.08.011_bb0050","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1159\/000506868","article-title":"Acute and persistent withdrawal syndromes following discontinuation of psychotropic medications","volume":"89","author":"Cosci","year":"2020","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.jad.2022.08.011_bb0055","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.addbeh.2018.08.027","article-title":"A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: are guidelines evidence-based?","volume":"97","author":"Davies","year":"2019","journal-title":"Addict. Behav."},{"key":"10.1016\/j.jad.2022.08.011_bb0060","series-title":"VA\/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder","year":"2022"},{"key":"10.1016\/j.jad.2022.08.011_bb0065","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000492693","article-title":"Discontinuing antidepressant drugs: lesson from a failed trial and extensive clinical experience","volume":"87","author":"Fava","year":"2018","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.jad.2022.08.011_bb0070","doi-asserted-by":"crossref","first-page":"19com12794","DOI":"10.4088\/JCP.19com12794","article-title":"Understanding and managing withdrawal syndromes after discontinuation of antidepressant drugs","volume":"80","author":"Fava","year":"2019","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2022.08.011_bb0075","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000370338","article-title":"Withdrawal symptoms after selective serotonin reuptake inhibitor discontinuation: a systematic review","volume":"84","author":"Fava","year":"2015","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.jad.2022.08.011_bb0080","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000491524","article-title":"Withdrawal symptoms after serotonin-noradrenaline reuptake inhibitor discontinuation: systematic review","volume":"87","author":"Fava","year":"2018","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.jad.2022.08.011_bb0085","series-title":"Guidelines for the Management of Depression and Anxiety Disorders in Primary Care","year":"2006"},{"key":"10.1016\/j.jad.2022.08.011_bb0090","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S2215-0366(19)30032-X","article-title":"Tapering of SSRI treatment to mitigate withdrawal symptoms","volume":"6","author":"Horowitz","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jad.2022.08.011_bb0095","first-page":"1","article-title":"Distinguishing relapse from antidepressant withdrawal: clinical practice and antidepressant discontinuation studies","author":"Horowitz","year":"2022","journal-title":"BJPsych Adv."},{"key":"10.1016\/j.jad.2022.08.011_bb0100","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2018.11.030","article-title":"Systematic reviews of clinical practice guidelines: a methodological guide","volume":"108","author":"Johnston","year":"2019","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.jad.2022.08.011_bb0105","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1177\/0706743716659417","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 3. Pharmacological treatments","volume":"61","author":"Kennedy","year":"2016","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.jad.2022.08.011_bb0110","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/0004867420979353","article-title":"The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders","volume":"55","author":"Malhi","year":"2021","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.jad.2022.08.011_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.jad.2022.08.011_bb0120","series-title":"Depression - The NICE Guideline on the Treatment and Management of Depression in Adults - Updated Edition","year":"2019"},{"key":"10.1016\/j.jad.2022.08.011_bb0130","series-title":"Depression in Adults: Treatment and Management","year":"2022"},{"key":"10.1016\/j.jad.2022.08.011_bb0135","series-title":"Medicines Associated With Dependence or Withdrawal Symptoms: Safe Prescribing and Withdrawal Management for Adults","first-page":"215","year":"2022"},{"key":"10.1016\/j.jad.2022.08.011_bb0140","series-title":"Identification of Common Mental Disorders and Managemente of Depression in Primary Care. An Evidence-based Best Practice Guideline","year":"2008"},{"key":"10.1016\/j.jad.2022.08.011_bb0145","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/j.1360-0443.2011.03686.x","article-title":"What is the difference between dependence and withdrawal reactions? A comparison of benzodiazepines and selective serotonin re-uptake inhibitors: SSRi and dependence","volume":"107","author":"Nielsen","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.jad.2022.08.011_bb0150","doi-asserted-by":"crossref","first-page":"350","DOI":"10.7326\/M15-2570","article-title":"Nonpharmacologic versus pharmacologic treatment of adult patients with major depressive disorder: a clinical practice guideline from the American College of Physicians","volume":"164","author":"Qaseem","year":"2016","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jad.2022.08.011_bb0155","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archpsyc.55.12.1121","article-title":"Treating major depression in primary care practice: an update of the Agency for Health Care Policy and Research practice guidelines","volume":"55","author":"Schulberg","year":"1998","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2022.08.011_bb0160","series-title":"Management of Perinatal Mood Disorders","article-title":"Management of perinatal mood disorders","year":"2012"},{"key":"10.1016\/j.jad.2022.08.011_bb0165","doi-asserted-by":"crossref","DOI":"10.1177\/20451253211067656","article-title":"Clinical practice guideline recommendations on tapering and discontinuing antidepressants for depression: a systematic review","volume":"12","author":"S\u00f8rensen","year":"2022","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.jad.2022.08.011_bb0170","series-title":"mhGAP Intervention Guide for Mental, Neurological and Substance Use Disorders in Non-specialized Health Settings. Version 2.0","year":"2016"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032722008618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032722008618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T03:23:18Z","timestamp":1759029798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032722008618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":33,"alternative-id":["S0165032722008618"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2022.08.011","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Description of antidepressant withdrawal symptoms in clinical practice guidelines on depression: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2022.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}